The low incidence of hematologic diseases in pediatric populations has constrained our ability to identify significant differences in the expression levels of CD103+CD3+ T cells, CD103+CD4+ T cells, and CD103+CD8+ T cells between patients in DN/RR states and HIs, primarily due to small sample sizes. The gene discussed is ITGAE; the disease is hematologic disorder.